This study aims at assessing additional performance characteristics of the SoundBite™ Crossing System with regards to the luminal passage of complex Chronic Total Occlusions (CTO) by evaluating clinically relevant efficacy, safety, cost benefit and treatment pathway endpoints.
This multinational study will be based on observational cases with descriptive statistics to collect data on safety and efficacy based on clinical use of the SoundBite™ Crossing System. This study will include a cost benefit analysis that will focus on wire and other Percutaneous Transluminal Angioplasty (PTA) device usage during the procedure. The cost benefit will be compared to the sites data on their average costs for CTO crossing cases. The planned treatment pathway elected prior to procedure will be compared to subject's treatment pathway plan post -procedure (discharge, surgeries such as bypass, amputation etc.) will be collected to determine patient outcomes.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
SoundBite™ Crossing System consisting of the SoundBite™ Console and SoundBite™ Active Wire 18. The Investigator may use the SoundBite™ Active Wire during the procedure to cross the proximal aspect and/or to cross multiple lesions.
Medical University of Graz
Graz, Austria
Klinikum Hochsauerland GmbH, Klinik für Angiologie
Arnsberg, Germany
Successful CTO Crossing assessed by angiographic imaging
Successful CTO Crossing using the SoundBite™ Crossing System (SCS)
Time frame: at time of procedure
Successful luminal CTO crossing using the SCS with or without imaging assistance.
Luminal crossing defined as ≥50% true lumen passage as assessed by an independent imaging core lab.
Time frame: at time of procedure
Costs benefits associated with the use of the SCS compared to a retrospective randomly selected chart review of conventional PTA wire escalation at the clinical site.
Imaging costs are excluded
Time frame: through study completion; 15 months
Freedom from SCS related Major Adverse Events (MAE) at the time of procedure/discharge
MAEs examples: unplanned, index limb amputation, dissection of grade C or greater that require an intervention to resolve
Time frame: at procedure until discharge; up to 48 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.